HB Wealth Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.04M Buy
4,638
+646
+16% +$161K 0.01% 646
2025
Q4
$962K Buy
3,992
+238
+6% +$60.9K 0.01% 640
2025
Q3
$1.03M Buy
3,754
+382
+11% +$104K 0.01% 594
2025
Q2
$870K Sell
3,372
-3
-0.1% -$716 0.01% 574
2025
Q1
$755K Buy
3,375
+301
+10% +$70.3K 0.01% 626
2024
Q4
$703K Buy
3,074
+26
+0.9% +$6.26K 0.01% 513
2024
Q3
$744K Buy
3,048
+317
+12% +$70.8K 0.01% 458
2024
Q2
$523K Buy
2,731
+481
+21% +$97.6K 0.01% 533
2024
Q1
$446K Buy
2,250
+92
+4% +$16.9K 0.01% 542
2023
Q4
$371K Buy
2,158
+652
+43% +$100K 0.01% 534
2023
Q3
$223K Buy
+1,506
New +$272K ﹤0.01% 671

Other funds holding RMD

HB Wealth Management's RMD Position: Q1 2026 in Review

HB Wealth Management increased its ResMed (RMD) stake by 16% in Q1 2026, buying an estimated $161K and bringing the position to 4,638 shares worth $1.04M. The position accounts for 0.01% of the portfolio, ranked #646.

HB Wealth Management first reported a position in RMD in Q3 2023 and has held it in 11 quarters since. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • HB Wealth Management held 4,638 shares of ResMed worth $1.04M as of Q1 2026.
  • HB Wealth Management bought 646 ResMed shares in Q1 2026, an estimated $161K.
  • ResMed made up 0.01% of HB Wealth Management's portfolio in Q1 2026, its #646 holding.
  • HB Wealth Management first reported a position in ResMed in Q3 2023 and has held it in 11 quarters since.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on HB Wealth Management's 13F filing for Q1 2026, filed 27 Apr 2026.